8
Oct
2024

ICURE

Exhibitor at CPHI Milan 2024 stand 16G12, Finished Dosage Formulations
About Us

ICURE Pharmaceutical Inc. is a biopharmaceutical company uniquely positioned to lead advances in Transdermal Drug Delivery Technology. ICURE is applying its advanced transdermal delivery technology into pharmaceutical and dermo-cosmetic patches. The core business of ICURE is based on ‘Cure & Care’ solution through the skin. ICURE is actively producing NSAIDS patches in Asian countries. ICURE is also producing systemic patches, such as nicotine and rivastigmine patches, and developing other innovative patch products, like Donepezil patches, in its R&D Center. ICURE’s goal is to be a glo...

Read more Show less
Categories
more categories Show less
  • KR
  • 2018
    On CPHI since
View company profile
Contact info
  • +82-10-9295-9313
  • 10, Bongeunsa-ro104-gil, Gangnam-gu, 06170, Seoul, Korea, Republic Of
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16G12, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Rivastigmine Patch

    Product Rivastigmine Patch

    Systemic patch for Alzheimer's disease and Parkinson's disease care.
  • Ketoprofen Plaster

    Product Ketoprofen Plaster

    Transdermal plaster for arthritis, peri-arthritis of shoulder, tendinitis, and myalgia.
  • Lidocaine Cataplasma

    Product Lidocaine Cataplasma

    Relief of pain associated with post-herpetic neuralgia.
  • Flurbiprofen plaster

    Product Flurbiprofen plaster

    Transdermal plaster for local pain, such as arthritis, peri-arthritiis of shoulder, tendinitis, and mylagia.
  • Nicotine Patch

    Product Nicotine Patch

    Systemic patch for nicotine replacement therapy